Professor Dame Nancy Rothwell (BSc, PhD, DSc, FMedSci, FRS) - personal details
Nancy Rothwell obtained a first class degree in Physiology in 1976, a PhD in 1978 and a DSc in 1987 from the University of London. Her early research identified mechanisms of energy balance regulation, obesity and cachexia. In 1984 she was awarded a Royal Society Research Fellowship and relocated to Manchester in 1987. Nancy was awarded a Chair in physiology in 1994, then a prestigious Medical Research Council Research Chair in 1998. Her current research focuses on the role of inflammation in brain disease and has identified the role of the cytokine interleukin-1 (IL-1) in diverse forms of brain injury. Her recent studies have begun to elucidate the mechanisms regulating IL-1 release and its action, and her group has conducted the first early clinical trial of an IL-1 inhibitor in stroke. She has previously served as president of the British Neuroscience Association, a council member of MRC, BBSRC and Cancer Research UK.
Nancy currently oversees a research group of about 20 scientists, with significant external funding, and is President & Vice-Chancellor at The University of Manchester. She has recently been a member of the Royal Society Council, Vice President of the Royal Society, Chair of the Royal Society Education Committee, and is currently President of the Society of Biology and a non-executive director of AstraZeneca. In 2003 she won the prestigious Pfizer Research Prize, in 2004 was elected a Fellow of the Royal Society and in 2005 was honoured with a DBE. She was recently appointed as Deputy Lieutenant for Greater Manchester, a member of the Prime Minister’s Council for Science and Technology and the Greater Manchester Local Enterprise Partnership.
Nancy takes a strong and active interest in public communication of science.